Drug
Rbp 6000
Rbp 6000: highest development phase Phase 3, developed by Indivior. 4 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Indivior
Trials
| Drug | Phase | Indication |
|---|---|---|
| RBP-6000 NCT02896296 | Phase 3 | Opioid Use Disorder |
| RBP-6000 NCT02765867 | Phase 1 | Opioid Use Disorder |
| RBP-6000 NCT02559973 | Phase 1 | Opioid Use Disorder |
| RBP-6000 NCT03002961 | Phase 1 | Opioid Use Disorder |
Latest
Follow Rbp 6000 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.